Ligand validation:3C1Y

2BA: (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8 ]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide

2BA is a Ligand Of Interest in 3C1Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3C1Y_2BA_A_358	92%	18%	0.078	0.968	1.35	2.18	5	15	6	0	100%	1
4YXM_2BA_B_401	69%	2%	0.135	0.951	4.38	2.41	17	13	0	0	100%	1
3C21_2BA_A_358	59%	15%	0.168	0.952	1.55	2.18	6	11	6	0	100%	1
4RLE_2BA_A_201	99%	22%	0.051	0.986	1.73	1.53	10	5	0	0	100%	1
4RWW_2BA_B_2001	98%	40%	0.062	0.986	1.02	1.29	3	6	0	0	100%	1
7B5U_2BA_A_301	97%	5%	0.073	0.987	4.05	1.34	12	5	4	0	100%	1
6IYF_2BA_B_401	97%	22%	0.066	0.978	1.87	1.37	15	7	0	0	100%	1
8AD6_2BA_A_201	95%	62%	0.071	0.975	0.7	0.75	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.